Predictors of responders for low-dose carperitide monotherapy in patients with acute heart failure
Sign Up to like & getrecommendations! Published in 2019 at "Heart and Vessels"
DOI: 10.1007/s00380-019-01450-w
Abstract: Human atrial natriuretic peptide, known as carperitide, is approved for early relief of dyspnea in patients with acute heart failure (AHF). However, the diuretic effect of carperitide is sometimes insufficient for controlling volume overload. We… read more here.
Keywords: heart; low dose; carperitide; dose carperitide ... See more keywords
Therapeutic strategy using low-dose carperitide monotherapy in patients with acute heart failure
Sign Up to like & getrecommendations! Published in 2020 at "Heart and Vessels"
DOI: 10.1007/s00380-020-01635-8
Abstract: Kamiya and colleagues demonstrated that higher systolic blood pressure > 135 mmHg and lower serum creatinine level < 0.795 mg/dL were significant predictors of clinically favorable diuretic response to low-dose human atrial natriuretic peptide carperitide… read more here.
Keywords: heart; low dose; carperitide; monotherapy patients ... See more keywords
Rationale and Design of Low-dose Administration of Carperitide for Acute Heart Failure (LASCAR-AHF)
Sign Up to like & getrecommendations! Published in 2017 at "Cardiovascular Drugs and Therapy"
DOI: 10.1007/s10557-017-6760-z
Abstract: BackgroundsDespite current therapies, acute heart failure (AHF) remains a major public health burden with high rates of in-hospital and post-discharge morbidity and mortality. Carperitide is a recombinantly produced intravenous formulation of human atrial natriuretic peptide… read more here.
Keywords: acute heart; ahf; carperitide; heart failure ... See more keywords